Literature DB >> 68658

Immunosuppression and the role of suppressive factors in cancer.

I Kamo, H Friedman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68658     DOI: 10.1016/s0065-230x(08)60636-3

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  36 in total

Review 1.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens.

Authors:  S Sano; Y Izumi; S Sugihara; H Nakajima; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Studies on the recovery from tolerance to tumor antigens. II. Accelerated recovery of tumor-specific effector T cells in tolerant mice by applying T-T cell interaction mechanism.

Authors:  S Sato; H Fujiwara; A Kosugi; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.

Authors:  N Yasutake; M Ohwaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Correlation if circulating immune complexes and disease status in patients with leukaemia.

Authors:  R A Hubbard; M C Aggio; B B Lozzio; C J Wust
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma.

Authors:  C E Jones; C T Lee; W Skinner; P Koyama; D Prescott
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.

Authors:  E Yefenof; A Meidav; E Kedar
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  Effect of quinonyl-N-acetyl muramyl dipeptide on immune responses in tumor-bearing mice.

Authors:  I Saiki; Y Tanio; K I Yamamoto; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.

Authors:  G J Pommier; F L Garrouste; D Bettetini; J M Culouscou; M M Remacle-Bonnet
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma.

Authors:  M Nelson; D S Nelson; V K Kuchroo; P B Spradbrow; P A Jennings
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.